Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Bitterness-Masking Effects of Different Beverages on Zopiclone and Eszopiclone Tablets.

Yoshida M, Kojima H, Uda A, Haraguchi T, Ozeki M, Kawasaki I, Yamamoto K, Yano I, Hirai M, Uchida T.

Chem Pharm Bull (Tokyo). 2019;67(5):404-409. doi: 10.1248/cpb.c18-00502.

2.

Association of CYP2D6 polymorphisms and extrapyramidal symptoms in schizophrenia patients receiving risperidone: a retrospective study.

Ito T, Yamamoto K, Ohsawa F, Otsuka I, Hishimoto A, Sora I, Hirai M, Yano I.

J Pharm Health Care Sci. 2018 Nov 19;4:28. doi: 10.1186/s40780-018-0126-y. eCollection 2018.

3.

3D Culture Represents Apoptosis Induced by Trastuzumab Better than 2D Monolayer Culture.

Tatara T, Mukohara T, Tanaka R, Shimono Y, Funakoshi Y, Imamura Y, Toyoda M, Kiyota N, Hirai M, Kakeji Y, Minami H.

Anticancer Res. 2018 May;38(5):2831-2839.

PMID:
29715106
4.

Association of Expression Levels or Activation Status of STAT3 with Treatment Outcomes of Sunitinib in Patients with Renal Cell Carcinoma.

Yamamoto K, Hara T, Nakagawa T, Hirai M, Miyake H, Fujisawa M, Yano I.

Target Oncol. 2018 Jun;13(3):371-378. doi: 10.1007/s11523-018-0563-4.

PMID:
29633072
5.

Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs.

Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hirai M.

Kobe J Med Sci. 2017 Jul 20;63(1):E9-E16.

6.

Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy.

Ioroi T, Furukawa J, Kume M, Hirata S, Utsubo Y, Mizuta N, Miyake H, Fujisawa M, Hirai M.

Support Care Cancer. 2018 May;26(5):1419-1423. doi: 10.1007/s00520-017-3967-2. Epub 2017 Nov 16.

PMID:
29147855
7.

Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback.

Kimura T, Uda A, Sakaue T, Yamashita K, Nishioka T, Nishimura S, Ebisawa K, Nagata M, Ohji G, Nakamura T, Koike C, Kusuki M, Ioroi T, Mukai A, Abe Y, Yoshida H, Hirai M, Arakawa S, Yano I, Iwata K, Tokimatsu I.

Infection. 2018 Apr;46(2):215-224. doi: 10.1007/s15010-017-1099-8. Epub 2017 Nov 13.

PMID:
29134582
8.

Effects of Ascorbyl-2-phosphate Magnesium on Human Keratinocyte Toxicity and Pathological Changes by Sorafenib.

Yamamoto K, Shichiri H, Ishida T, Kaku K, Nishioka T, Kume M, Makimoto H, Nakagawa T, Hirano T, Bito T, Nishigori C, Yano I, Hirai M.

Biol Pharm Bull. 2017;40(9):1530-1536. doi: 10.1248/bpb.b17-00386.

9.

Effect of dietary fatty acid and micronutrient intake/energy ratio on serum diamine oxidase activity in healthy women.

Miyoshi M, Ueno M, Matsuo M, Hamada Y, Takahashi M, Yamamoto M, Yamamoto I, Mikajiri R, Tabuchi S, Wakida K, Yamanishi M, Hirai M, Usami M.

Nutrition. 2017 Jul - Aug;39-40:67-70. doi: 10.1016/j.nut.2017.03.004. Epub 2017 Mar 28.

PMID:
28606572
10.
11.

Prevalence of inappropriate antibiotic prescriptions after the great east Japan earthquake, 2011.

Iwata K, Fukuchi T, Hirai M, Yoshimura K, Kanatani Y.

Medicine (Baltimore). 2017 Apr;96(15):e6625. doi: 10.1097/MD.0000000000006625.

12.

Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients.

Watanabe A, Yamamoto K, Ioroi T, Hirata S, Harada K, Miyake H, Fujisawa M, Nakagawa T, Yano I, Hirai M.

Biol Pharm Bull. 2017;40(4):458-464. doi: 10.1248/bpb.b16-00875.

13.

Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy.

Kawara F, Fujita T, Morita Y, Uda A, Masuda A, Saito M, Ooi M, Ishida T, Kondo Y, Yoshida S, Okuno T, Yano Y, Yoshida M, Kutsumi H, Hayakumo T, Yamashita K, Hirano T, Hirai M, Azuma T.

World J Gastroenterol. 2017 Mar 21;23(11):2060-2067. doi: 10.3748/wjg.v23.i11.2060.

14.

Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.

Mori H, Arita K, Yamaguchi T, Hirai M, Kurebayashi Y.

Kobe J Med Sci. 2016 Sep 9;62(4):E79-E88.

15.

Prostaglandin E1 reduces the keratinocyte toxicity of sorafenib by maintaining signal transducer and activator of transcription 3 (STAT3) activity and enhancing the cAMP response element binding protein (CREB) activity.

Shichiri H, Yamamoto K, Tokura M, Ishida T, Uda A, Bito T, Nishigori C, Nakagawa T, Hirano T, Yano I, Hirai M.

Biochem Biophys Res Commun. 2017 Apr 1;485(2):227-233. doi: 10.1016/j.bbrc.2017.02.107. Epub 2017 Feb 24.

PMID:
28237700
16.

Changes in blood concentrations of trace metals in cancer patients receiving cisplatin-based chemotherapy.

Nakamura T, Takahashi M, Niigata R, Yamashita K, Kume M, Hirai M, Yasui H.

Biomed Rep. 2016 Dec;5(6):737-744. doi: 10.3892/br.2016.789. Epub 2016 Oct 24.

17.

Effects of VLA-1 Blockade on Experimental Inflammation in Mice.

Totsuka R, Kondo T, Matsubara S, Hirai M, Kurebayashi Y.

Kobe J Med Sci. 2016 Jul 5;62(2):E27-37.

18.

STAT3 polymorphism rs4796793 may be a predictive factor of tumor response to multiple tyrosine kinase inhibitors in metastatic renal cell carcinoma in Japanese population.

Yamamoto K, Ioroi T, Kanaya K, Shinomiya K, Komoto S, Hirata S, Harada K, Watanabe A, Suno M, Nishioka T, Kume M, Makimoto H, Nakagawa T, Hirano T, Miyake H, Fujisawa M, Hirai M.

Med Oncol. 2016 Mar;33(3):24. doi: 10.1007/s12032-016-0733-0. Epub 2016 Jan 30.

PMID:
26833481
19.

Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines.

Mizumoto A, Yamamoto K, Nakayama Y, Takara K, Nakagawa T, Hirano T, Hirai M.

J Pharmacol Exp Ther. 2015 Nov;355(2):152-8. doi: 10.1124/jpet.115.226639. Epub 2015 Aug 25.

PMID:
26306766
20.

Association of Single Nucleotide Polymorphisms in STAT3 with Hand-Foot Skin Reactions in Patients with Metastatic Renal Cell Carcinoma Treated with Multiple Tyrosine Kinase Inhibitors: A Retrospective Analysis in Japanese Patients.

Yamamoto K, Shinomiya K, Ioroi T, Hirata S, Harada K, Suno M, Nishioka T, Kume M, Makimoto H, Nakagawa T, Hirano T, Bito T, Nishigori C, Miyake H, Fujisawa M, Hirai M.

Target Oncol. 2016 Feb;11(1):93-9. doi: 10.1007/s11523-015-0382-9.

PMID:
26300443

Supplemental Content

Loading ...
Support Center